Print Friendly, PDF & Email

NCT/Study#

NA /

RAPA-201-STP-01

Phase II Trial Of Autologous Rapamycin-Resistant Th1/Tc1 (RAPA-201) Cell Therapy Of Checkpoint Therapy Resistant Solid Tumors

DISEASE GROUP:

Phase 1 Clinical Trials

current phase:

Phase II

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587